2022 annual financial data
Travere Therapeutics 2022 Operating margin
Direct answer
Operating margin was -292.17%.
Operating income was -319,813,000 USD and net income was -278,482,000 USD.
Operating cash flow was -186,291,000 USD.
Get free Travere Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 109,460,000 USD
- Operating income
- -319,813,000 USD
- Net income
- -278,482,000 USD
- Operating cash flow
- -186,291,000 USD